Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Daily open opportunities, newly observed postings, hiring breadth, and normalized monthly compensation for jobs in this pillar.
As of 2026-09-23
Distinct employers
+14 vs prior week
7 days vs previous 7 days
Remote pay is separated from onsite and hybrid pay so expensive cities do not distort the remote benchmark.
Onsite + hybrid
11 salary listings from this company
11 open jobs at 1 hiring companies
| Country market | Open jobs | Hiring companies | Median | Middle 50% | Evidence |
|---|---|---|---|---|---|
| United States | 8 | 1 | $16.8K/mo | $15.5K/mo – $22.5K/mo | 8 salary listings from this companyLimited |
| United Kingdom | 3 | 1 | $10.2K/mo | $9.2K/mo – $12.3K/mo | 3 salary listings from this companyLimited |
Open jobs are current; salary evidence covers the past 12 months and also uses closed postings. Every place rolls up through its canonical city, region, country, and continent hierarchy exactly once.
Open roles, employers, and newly listed jobs by day
Historical context; use the work-market split above for current pay
Earlier open counts are estimated from observation dates. Offline postings are never inferred open for more than 90 days; new daily samples are exact snapshots.
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding history
Recursion Pharmaceuticals, Inc. is a public clinical-stage TechBio company headquartered in Salt Lake City, Utah. Its Recursion OS integrates biology, chemistry, clinical development, multimodal data, and purpose-built AI models.
Recursion Pharmaceuticals, Inc. is a public clinical-stage TechBio company headquartered in Salt Lake City, Utah. Its Recursion OS integrates biology, chemistry, clinical development, multimodal data, and purpose-built AI models.
14 open jobs
Recursion·2 days ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·2 days ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·5 days ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·5 days ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·2 weeks ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·4 weeks ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
Recursion·4 weeks ago
Clinical-stage TechBio company using an AI-native platform, automated experiments, and proprietary biological and chemical data to discover and develop medicines.
Funding
